Investigation of the Effect of Magnetite Nanoparticles (MCS-B) on Human Platelet Aggregation
Andrey N. Belousov
Abstract
Background: Currently, one of the main problems that happens in the treatment by extracorporeal methods of hemosorption is systemic shifts in homeostasis. Among these complications the most significant are blood cells traumatization and hemorrhage. Direct physical contact of blood with sorbent surface causes activation of a multistage reaction of thrombosis. Now, new methods of hemosorption using non-traumatic sorbents are being actively developed. Wide introduction of nanotechnological preparations (magnetite nanoparticles) in clinical medicine allows improving methods of hemocorrection, creating a new class magnetically sorbent.
The aim of this study is to know the activity of magnet-controlled sorbent inhibiting the aggregation of platelets in an in vitro model.
Materials and Methods: 0.9% NaCl, magnetite nanoparticles of magnet-controlled sorbent (MCS-B brand). Object of research: platelets in relatively healthy volunteers. Quantitative determination aggregation of platelets activity by using aggregometer A-1 was carried out by the Bornov's method in the modification of Zachary and Kinah.
Results and discussions: The results of the study showed that the use of NaCl saline solution shifts the colloidal suspension equilibrium of platelets towards a significant (P<0.001) increase in the rate and index of their aggregation. For the first time, the effect of 0.9% NaCl on function of platelets makes us reconsider the concept of safety of infusion solutions in patients with initial signs of platelet disorders hemostasis. On the contrary, the use of MCS-B nanoparticles significantly revealed (P<0.05) an increase in the stability of colloidal suspension of platelets. This is an important pathogenetic factor which affects the occurrence of correction of hemostasis in conditions of blood clotting disorders.
Keywords
References
1. Andrews RK, Berndt MC. Platelet physiology and thrombosis. Thromb Res. 2004;114(5-6):447-53. doi: 10.1016/j.thromres.2004.07.020.
2. Stalker TJ, Traxler EA, Wu J, Wannemacher KM, Cermignano SL, Voronov R, et al. Hierarchical organization in the hemostatic response and its relationship to the platelet-signaling network. Blood. 2013;121(10):1875-85. doi: 10.1182/blood-2012-09-457739.
3. Senis YA, Mazharian A, Mori J. Src family kinases: at the forefront of platelet activation. Blood. 2014;124(13):2013-24. doi: 10.1182/blood-2014-01-453134.
4. Li Z., Delaney MK, O'Brien KA, Du X. Signaling during platelet adhesion and activation. Arterioscler. Thromb Vasc Biol. 2010;30(12):2341-9. doi: 10.1161/ATVBAHA.110.207522.
5. Brass LF, Tomaiuolo M, Stalker TJ. Harnessing the platelet signaling network to produce an optimal hemostatic response. Hematol Oncol Clin. North Am. 2013;27(3):381-409. doi: 10.1016/j.hoc.2013.02.002.
6. van der Meijden PEJ, Heemskerk JWM. Platelet biology and functions: new concepts and clinical perspectives. Nat Rev Cardiol. 2019;16(3):166-179. doi: 10.1038/s41569-018-0110-0.
7. Chang TMS, Endo Y, Nikolaev VG. Hemoperfusion, plasmaperfusion and other clinical uses of general, biospecific, immuno and leucocyte adsorbents. Series: Regenerative Medicine, Artificial Cells and Nanomedicine – Vol 4. New Jersey: World Scientific; 2017. ISBN: 9789814749077.
8. Holodov JA. Magnetism in biology. М. Science; 1970.
9. Zenkov NZ, Маrcheko YY, Тоfimov АV. The role of radical processes in the magnetosensitivity of the human body. In: Magnetic fields in biology, medicine and agriculture / Abstracts of II Region of Science. Center for new information technologies. Rostov-on-Don;1985:20-21.
10. Ponomarenko GN. Electromagnetometry and phototherapy. SPb.: Peace and family;1995.
11. Jancovich BD, Goldfarb JS, Misulovin JI. Magnetic hemotherapy as an effective resuscitation technique for treatment of acute axogenic poisoning. Curr Toxicol. 1993;1(2):133-9).
12. Oberhofer M. Advances in Radiation Protection. Kluwer Academic Publishers. The Netherlands; 1991. ISBN: 0-7923-1232-5.
13. Fröhlich E. Action of Nanoparticles on Platelet Activation and Plasmatic Coagulation. Curr Med Chem. 2016;23(5) 408-430. doi: 10.2174/0929867323666160106151428.
14. Frank VА. The use of magnetically sensitive ointments in purulent surgery. 5th All-Union meeting on the physics of magnetic fluids. Perm; 1990:115-16.
15. Аhalaya МG, Zakaraya КА, Какиаshvily МS. Obtaining and physical-chemical properties of magnetic fluids for biomedical applications. Materials of the 3rd All-Union school-seminar on magnetic liquids. М. МSU;1983:11-2.
16. Permichev АN, Cybusov SN, Bulanov GА. Magnetically controlled hemosorption. Abstracts of 7th international Pless conference on magnetic fluids. Application in biology and medicine. Pless;1996:124-5.
17. Belousov АN. Extracorporeal hemocorrection using magnetically controlled sorbent in intensive therapy of intoxication syndrome in patients with pathology of hepatopancreatoduodenal zone: Abstract of the dissertation for the degree of DM: 14.01.30. DSMA-Dnepropetrovsk;2004.
18. González De La Cruz G, Rodríguez-Fragoso P, Reyes-Esparza J. Unraveling the Safety Profile of Nanoscale Particles and Materials - From Biomedical to Environmental Applications. In: Interaction of Nanoparticles with Blood Components and Associated Pathophysiological Effects. IntechOpen;2018. doi: 10.5772/intechopen.69386.
19. Belousov AN. Sorbent for extracorporeal detoxification of biological liquids: State Patent No. 24322A UA A61N2/00. Publ. 17.07.98. Bull. No. 7.
20. Belousov AN. Method of extracorporeal detoxification of biological fluids: State Patent No. 24183A UA A61N2/00. Publ. 17.07.98. Bull. No. 7.
21. Belousov AN. Method of production of a magnetic liquid for transport and retention of medicines in organism Patent of Ukraine №14817А UA A61N2/00 / № 96062463. Decl. 21.06.96; Publ. 18.02.97.
22. Belousov AN. Therapeutic and prophylactic product "Micromage-B". State patent No. 30538A UA A 23L 1/304 No. 98052704 Decl. 25.05.98. Publ. 15.11.00. Bull. No. 6-11.
23. Belousov АN. The use of magnetite nanoparticles in applied medicine. International Journal of Nano Dimension. 2011;2(1):25-8.
24. Belousov AN, Belousova EY. The first steps in discovery new mechanisms of cellular regulation in means by nanotechnology preparations. X International Conference New Information Technologies in Medicine and Ecology. Yalta, Gursuf; 2002:420-5.
25. Belousov AN, Belousova EY. Mechanisms cell regulation by nanotechnology preparations (MCS-B). BioNanotech Conference & Expo. Santa Clura, CA, USA;2012.
26. Belousov AN. Effect of magnet controlled sorbent on parameters of acid-base balance of the blood and the processes of glycolysis in erythrocytes. Pain, anesthesia and intensive care. 2000;1:263-5.
27. Belousov AN., Nevzorov VP. Ultrastructure of cells in the kidneys and lungs of rabbits after administration of magnetite. International collection of scientific papers IV Scientific and Practical Conference on the Creation and Testing of New Drugs. Moscow;1997(4):77-87.
28. Belousov AN, Nevzorov VP. Ultrastructure of liver cells after administration of magnetite. International collection of scientific papers IV Scientific and Practical Conference on the Creation and Testing of New Drugs. Moscow; 1997:4:71-7.
29. Belousov AN. Spectrum of Application Magnetite Nanopaticles in Medicine. Nanotech. 2009;2(3):154-7.
30. Belousov AN. Effect on hemolysis and transport ATPase activity of erythrocytes by means nanopareticles of magnetit controlled sorbent (MCS-B). Pain, anesthesia and intensive care. Kiev. 2012;1:26-8.
31. Belousov AN. New Prospects Application of Magnetite Nanoparticles for the Diagnosis of Malignant Tumors in MRI Investigation. J Cell Mol Biol. 2017;2:004.
32. Belousov AN. Nanotechnology and Discovery of a New Factor Which Influences on Permeability of Erythrocytes and Eryptosis. Journal of Materials Science and Engineering. 2014;4(11): 367-72. doi: 10.17265/2161-6213/2014.11.008.
33. Belousov AN, Voyda Y, Belousova E. Influence of Physical Factors Caused by Magnetite Nanoparticles on Different Groups of Microorganisms. Journal of Nanotechnology and Materials Science. 2015.2(2):1-4.
34. Laloy J, Minet V, Alpan L. Impact of silver nanoparticles on haemolysis, platelet function and coagulation. Nanobiomedicine. 2014;4:1-9. doi: https://doi.org/10.5772/59346.
35. Order of the Ministry of health of the USSR No. 960 of 15.10.74 "on unification of clinical and laboratory research methods". A simplified means of determining platelet AG-regulation and disaggregation by born in the modification of Zachary, Kinah.
36. Berkovsky AL, Vasiliev SA, Zherdeva LV. Manual on the increase of adhesive-aggregation activity of platelets; 2002.
37. Severina IS, Busygina OG, Pyatakova NV. Activation of soluble GU-anilate cyclase by new NO donors as a basis for directed search for new effective vasodilators and antiplatelets. Bulletin of the Russian Academy of medical Sciences. 2000;4:25-30.
38. Chirkov YY, Belushkina NN, Tyschuk IA, Severina IS. The Role of guanylate cyclase in the regulation of human platelet aggregation. Bulletin of the USSR Academy of medical Sciences. 1991;10:51-5.
39. Belousov AN. Influence of a new method of extracorporeal hemocorrection with the use of a magnetically controlled sorbent on the blood circulation system in patients with intoxication syndrome. Medicine today and tomorrow, Kharkiv state medical University. 2000;1:85-9.
40. Movshovich IM, Shilo MA. On the effect of MF on biological systems. In: Proceedings of the 2nd All-Union meeting on the study of the influence of magnetic fields on biological objects; 1969.
41. Lezhenina NF, Rodionov VN. The method of clinical toxometry in assessing the effectiveness of treatment of toxic encephalopathy in the somatogenic phase of acute poisoning. In: Theoretical and clinical issues of modern reanimatology progress. Proceedings of the international Symposium; 1999.
42. Klassen VI. On the influence of weak magnetic fields on water systems. In: Reaction of biological systems to weak magnetic fields. Proceedings of the All-Union Symposium; 1971.
43. Kovalchuk AV. On some mechanisms of action of PMF on biological objects. In: Reaction of biological systems to weak magnetic fields. Proceedings of the All-Union Symposium; 1971.
44. Luzhnikov EA, Goldfarb YS. Physiohemotherapy of acute poisoning. M.: Medpraktika; 2002.
45. Piccardi G. L’influence des phenomenes terretres, solaires et cosmiques sur les reactions phisico-chimiques et biologiques. Bruxelles; 1956.
46. Straub KD, Carver P. Effects of electromagnetic fields on microsomal ATPase and mitochondrial oxidative phosphorylation. Ann. N.Y. Acad. Sci. 1975;6:247-54.
Submitted date:
12/16/2019
Reviewed date:
12/21/2019
Accepted date:
12/26/2019
Publication date:
12/26/2019
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email